PET/MRI in Oncological Imaging: State of the Art.
View/ Open
Date
2015-07-21ICR Author
Author
Bashir, U
Mallia, A
Stirling, J
Joemon, J
MacKewn, J
Charles-Edwards, G
Goh, V
Cook, GJ
Type
Journal Article
Metadata
Show full item recordAbstract
Positron emission tomography (PET) combined with magnetic resonance imaging (MRI) is a hybrid technology which has recently gained interest as a potential cancer imaging tool. Compared with CT, MRI is advantageous due to its lack of ionizing radiation, superior soft-tissue contrast resolution, and wider range of acquisition sequences. Several studies have shown PET/MRI to be equivalent to PET/CT in most oncological applications, possibly superior in certain body parts, e.g., head and neck, pelvis, and in certain situations, e.g., cancer recurrence. This review will update the readers on recent advances in PET/MRI technology and review key literature, while highlighting the strengths and weaknesses of PET/MRI in cancer imaging.
Collections
Language
eng
Date accepted
2015-07-10
License start date
2015-07-21
Citation
Diagnostics (Basel, Switzerland), 2015, 5 (3), pp. 333 - 357
Publisher
MDPI AG